Events
Review past presentations by Nilogen at key scientific meetings such as AACR and SITC, as well as forthcoming events for the coming year.
Drug Type
- Small Molecule/Tyrosine Kinase Inhibitors
- Adoptive Cell Therapies
- Antibody Dependent Cellular Cytotoxicity
- Checkpoint Inhibitors
- Cell Therapies
- Antibody Drug Conjugates
- Other
Cancer Type
- Lung
- Kidney
- Brain
- NSCLC
- HNSCC
- Renal
- Colorectal
- Bladder
- Other
Need Help?
Contact Us for support
May 25, 2021
STING & TLR Targeting Therapies Summit – Nilogen presenting
April 10, 2021
AACR 2021: A virtual meeting. Nilogen will present 3 posters during AACR 2021.
October 21, 2020
Evaluating the effectiveness of targeting ADC therapy in a patient-derived ex vivo tumoroid model, 3D-EX, for quantitative tumor cell killing
October 21, 2020
Determining the efficacy of ADCC by the 3D-EXSM ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment
November 1, 2020
An ex vivo tumoroid model of fresh patient tumors (3D-ACTSM) to assess efficacy of cellular therapy in immuno-oncology
